Targeting IL-17 for pancreatic cancer prevention.
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX.
Florencia
F
McAllister
The David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY.
Steven D
SD
Leach
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000276:immunology; D001241:Aspirin / Q000008:administration & dosage; D021441:Carcinoma, Pancreatic Ductal / Q000517:prevention & control*; D006801:Humans; D020381:Interleukin-17 / Q000037:antagonists & inhibitors / Q000276:immunology*; D058990:Molecular Targeted Therapy; D010190:Pancreatic Neoplasms / Q000276:immunology / Q000517:prevention & control*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D020381:Interleukin-17; D001241:Aspirin